DAVIS THOMAS ANDREW (CHIEF MEDICAL OFFICER) sold 3.8% of their position (2.72K shares) of GENOCEA BIOSCIENCES, INC. on the open market
Open‑market sale worth $3.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2022ACC: 0001457612-22-000028
Officer· CHIEF MEDICAL OFFICER
Since Oct 2018
+122.28K
Net shares
Net buyer
$3.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
125K acquired · 2.72K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+31.25K
Price / share
—
Trade value
—
% of position
76.4%
3/15/2022
40.89K→72.14K
Common Stock
Direct
Shares
−2.72K
Price / share
$1.10
Trade value
$2.99K
% of position
3.8%
3/16/2022
72.14K→69.42K
Total
Net shares
+28.53K
Net value
-$2.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2022 | A · Award | +31.25K | — | — | 76.4% | 40.89K | 72.14K |
| Common Stock Direct | 3/16/2022 | S · Sale | −2.72K | $1.10 | $2.99K | 3.8% | 72.14K | 69.42K |
| Total | +28.53K | -$2.99K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
93.75K shares
Shares
+93.75K
Strike price
1.11
Held after
93.75K
Exercisable
—
3/15/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock93.75K shares | 3/15/2022 | A · Award | +93.75K | 1.11 | — | 93.75K |